GEORGETOWN, Guyana, Dec. 11, CMC – The government of Guyana intends to purchase an anti-retroviral known as lenacapavir, that scientists say can offer protection against Human Immuno-deficiency Virus (HIV) that causes Acquired Immune Deficiency Syndrome (AIDS) up to six months.
You have read your free article
Create a free account to keep reading. Two articles each month, plus the daily CANANews newsletter.
CANANews is the Caribbean’s regional wire. Your subscription supports independent newsroom coverage from across the region.